Principal Investigators Perform First Implant of Investigational Medical Device Designed to Expand Applicability of Minimally Invasive Alternative... ...http://newsr.in/n/Press+Releases/754zwtqgn/Medtronic-Starts-Clinical-Study-of-Endurant-Evo-AAA.htm
Results Presented at European Association for the Study of the Liver (EASL) Meeting in Vienna, Austria PALO ALTO, California , April 27, 2015... ...http://in.advfn.com/p.php?pid=nmona&article=66586148
(GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced completion of the rolling submission of a New Drug Application (NDA)... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=68402
Comments April 27, 2015 - Vancouver, BC VANCOUVER, BC--(Marketwired - April 27, 2015) - Advanced Proteome Therapeutics Corporation ("APC" or the... ...http://andhranews.net/Business/2015/Advanced-Proteome-Therapeutics-Reports-Successful-Fusion-16539.htm
Singapore: US Food and Drug Administration has approved Eli Lilly's ramucirumab (Cyramza) for use in combination with Folfiri, chemotherapy regimen... ...http://www.biospectrumasia.com/biospectrum/regulatory/221085/fda-approves-eli-lillys-combination-drug-metastatic-colorectal-cancer?WT.rss_f=Pharma&WT.rss_a=FDA+approves+Eli+Lilly%27s+combination+drug+for+metastatic+colorectal+cancer
Get trained on FDAâÂ€Â™s regulatory...
This CAPA training for medical device...